UPCC 43419: Prospective Study of Immune Biomarkers in Patients with Multiple Myeloma

Brief description of study

The objective of this exploratory observational cohort study is to obtain blood samples - and in some cases, bone marrow aspirate samples - from patients with multiple myeloma for study in the laboratory.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    myeloma
  • Age: - 99 Years
  • Gender: All
Updated on 09 Mar 2024. Study ID: 834039
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center